In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $100.00. The company’s shares closed last ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In a financial audit, inherent risk is most likely to occur when transactions are complex or in situations that require a high degree of judgment in regard to financial estimates. This type of ...
After hours: 7:51:05 p.m. EST ...
After hours: 7:07:16 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback